Black Rock Inc. Gilead Sciences, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 120,632,023 shares of GILD stock, worth $15 Billion. This represents 0.19% of its overall portfolio holdings.

Number of Shares

120,632,023

Previous 122,531,027 1.55%

Holding current value

$15 Billion

Previous $8.98 Billion 7.79%

% of portfolio

0.19%

Previous 0.21%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $120 Million - $138 Million	-1,899,004 Reduced 1.55%	120,632,023 $8.28 Billion
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $18.8 Million - $22.9 Million	-261,984 Reduced 0.21%	122,531,027 $8.98 Billion
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $251 Million - $284 Million	-3,422,449 Reduced 2.71%	122,793,011 $9.95 Billion
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1.57 Million - $1.72 Million	21,281 Added 0.02%	126,215,460 $9.46 Billion
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $27.5 Million - $31.4 Million	-362,347 Reduced 0.29%	126,194,179 $9.73 Billion

Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $387 Million - $441 Million	-5,003,724 Reduced 3.8%	126,556,526 $10.5 Billion
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $193 Million - $277 Million	3,099,517 Added 2.41%	131,560,250 $11.3 Billion
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $90.7 Million - $104 Million	1,523,122 Added 1.2%	128,460,733 $7.92 Billion
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $302 Million - $340 Million	5,228,246 Added 4.3%	126,937,611 $7.85 Billion
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $159 Million - $199 Million	2,748,159 Added 2.31%	121,709,365 $7.24 Billion
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $131 Million - $149 Million	-2,021,143 Reduced 1.67%	118,961,206 $8.64 Billion
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $191 Million - $206 Million	-2,822,189 Reduced 2.28%	120,982,349 $8.45 Billion
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $7.86 Billion - $8.59 Billion	123,804,538 New	123,804,538 $8.53 Billion

Others Institutions Holding GILD

# of Institutions

2,369

Shares Held

1.01B

Call Options Held

8.63M

Put Options Held

7.39M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account